SR
Swayampakula Ramakanth HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
111
Avg Return
Past Year
Past Year
30%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
92.9%
Neutral
7.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Technology
Financials
Asset Management
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Technology
Software - Infrastructure
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $37 |
120%
upside
| 1 | +6.8% |
0
%
| 2 Mar ‘26 4 days ago |
|
|
|
Buy
Maintained
| $64 |
90%
upside
| 1 | -11% |
0
%
| 27 Feb ‘26 7 days ago |
|
|
|
Buy
Maintained
| $60 |
77%
upside
| 4 | -1.3% |
0
%
| 25 Feb ‘26 9 days ago |
|
|
|
Buy
Maintained
| $18 |
163%
upside
| 1 | -25% |
0
%
| 26 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $130 |
51%
upside
| 2 | +15% |
0
%
| 26 Jan ‘26 1 month ago |
|
|
|
Buy
Reiterated
| $30 |
230%
upside
| 1 | -5% |
0
%
| 9 Jan ‘26 1 month ago |
|
|
|
Buy
Initiated
| $4 |
92%
upside
| 1 | +34% |
0
%
| 7 Jan ‘26 1 month ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | +56% |
0
%
| 31 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $7 |
411%
upside
| 1 | +8.8% |
0
%
| 19 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $8 |
236%
upside
| 1 | -9.9% |
0
%
| 18 Dec ‘25 2 months ago |
|